Chi square distribution analysis showed that 95.5% grade II, 79.2% grade III and 58.2% grade IV glioma patients express higher Bax in (P < 0.003) and 68.8% relapsed patients vs. 94.4% non-relapsed patients express higher Bax (P < 0.027). This evidence concerns the gene BAX and glioma.